Xelafaslatide

Xelafaslatide is a Fatty acid synthase (Fas) receptor antagonist.

2040964-58-5

ONL-1204

12352209

Fatty Acid Synthase (FASN)

Metabolic Enzyme/Protease

Metabolism-sugar/lipid metabolism

Metabolic Disease

99.88

DMSO : 100 mg/mL (ultrasonic)

OC(C=C1)=CC=C1C[C@H](NC([C@H](CC(N)=O)NC([C@H](C(C)C)NC([C@H](C)NC(CNC([C@H](CC(C)C)NC([C@@H](NC([C@H]([C@@H](C)CC)NC([C@@H](NC([C@@H](N)CC2=CN=CN2)=O)CC3=CN=CN3)=O)=O)CC4=CC=C(C=C4)O)=O)=O)=O)=O)=O)=O)C(N[C@@H]([C@@H](C)CC)C(N[C@H](C(N)=O)CC5=CC=C(C=C5)O)=O)=O

C71H100N18O16

1461.66

[1]Krishnan A, et al. A small peptide antagonist of the Fas receptor inhibits neuroinflammation and prevents axon degeneration and retinal ganglion cell death in an inducible mouse model of glaucoma. J Neuroinflammation. 2019 Sep 30;16 (1) :184.

Blue Ice

-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)

http://file.medchemexpress.com/batch_PDF/HY-P10227/Xelafaslatide-SDS-MedChemExpress.pdf

Peptides

Phase 2